title: Successful treatment of fistulizing Crohn's disease with certolizumab pegol.
authors.forename: Silvio
authors.initials: S
authors.lastname: Danese
authors.forename: Tommaso
authors.initials: T
authors.lastname: Stefanelli
authors.forename: Paolo
authors.initials: P
authors.lastname: Omodei
authors.forename: Stefania
authors.initials: S
authors.lastname: Zatelli
authors.forename: Cristiana
authors.initials: C
authors.lastname: Bonifacio
authors.forename: Luca
authors.initials: L
authors.lastname: Balzarini
authors.forename: Alessandro
authors.initials: A
authors.lastname: Repici
authors.forename: Alberto
authors.initials: A
authors.lastname: Malesci
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized; D000068582:Certolizumab Pegol; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D007412:Intestinal Fistula / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007140:Immunoglobulin Fab Fragments; D007155:Immunologic Factors; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol